The agreement with BNW Real Estate Development LLC positions NewGenDigital to maximize the profitability of its recently acquired plot of land in the UAE Potential net return for the project is estimated to be as high as US$67 million per a feasibility study compiled by BNW BANGKOK, July 21, 2025 (GLOBE NEWSWIRE) -- NewGenIvf Group Limited (NASDAQ: NIVF) (“NewGen” or the “Company”), a comprehensive fertility services provider in Asia helping couples and individuals obtain access to fertility treatments, tod ...

Core Insights - NewGenIvf Group Limited's subsidiary, NewGenDigital, has secured a strategic plot of land in Ras Al Khaimah, UAE, and is exploring the feasibility of issuing digital tokens tied to this plot as part of a blockchain asset digitization strategy [1][3] - The real estate project associated with the plot is projected to generate sales revenue exceeding US$400 million, indicating significant potential for financial returns [1][4] - The plot, measuring 110,400 sq. ft. with an estimated saleable area of approximately 527,750 sq. ft., is located in a prime beachfront area, benefiting from the region's economic growth and investor-friendly policies [2][4] Company Strategy - NewGenDigital aims to leverage Real World Asset (RWA) tokenization, which transforms physical assets like real estate into digital tokens, enhancing ownership management and liquidity [3] - The UAE's regulatory environment, including the establishment of the Ras Al Khaimah Digital Assets Oasis Free Zone and the Virtual Asset Regulatory Authority, supports NewGenDigital's blockchain initiatives [3] - The company's strategic move into the digital asset space aligns with its broader investment initiative of US$45 million in the UAE real estate market [1][3] Market Context - The Ras Al Khaimah region is poised for growth, particularly with the upcoming Wynn Al Marjan Island integrated resort set to open in early 2027, which is expected to further enhance the area's attractiveness for investment [2] - NewGenDigital's entry into the region is welcomed by local developers, indicating a collaborative environment for international brands and developers [4]

Core Insights - NewGen plans to invest US$45 million in the UAE real estate market, focusing on properties near the Wynn Al Marjan Island integrated resort, marking a diversification from its traditional IVF business operations [1][2] - The investment is driven by Ras Al Khaimah's strong economic growth, political stability, and significant infrastructure developments, which are expected to enhance property values [2][5] - NewGen is also considering additional investments in Abu Dhabi's real estate market, which offers stability and long-term growth potential [2][3] Investment Strategy - The company has engaged UAE-based business development manager Samira Aissani to lead property acquisition initiatives, leveraging her extensive experience in UAE real estate [3] - NewGen is in advanced discussions for strategic plot acquisitions in Ras Al Khaimah and has established partnerships with prominent UAE developers [3][4] - A term sheet has been executed with Enclave Capital LLC to raise an additional US$45 million to support the UAE real estate expansion [4] Market Potential - The Wynn Al Marjan Island integrated resort, a multi-billion dollar development set to open in early 2027, is expected to drive demand for real estate in Ras Al Khaimah [2] - The region's strategic location, with 31% of the world's population within four hours' flying time, along with favorable investment policies, creates an ideal environment for real estate appreciation [2] - NewGen's CEO expressed confidence that the investment will deliver substantial returns and establish a strong foundation for future growth [5]

Core Insights - NewGen is expanding its digital asset portfolio by investing US$30 million in staking Solana, demonstrating a commitment to blockchain technology [1][2][3] - The investment will be financed through existing credit facilities totaling US$126 million [1] - This move follows an initial US$1 million investment in Bitcoin made in December 2024, indicating management's confidence in blockchain assets [3][4] Company Strategy - NewGen plans to establish a dedicated subsidiary focused on digital asset operations and investments, enhancing operational focus and strategic flexibility [3] - The investment in Solana is seen as a natural evolution of the company's digital asset strategy, reflecting a growing conviction in digital assets as a legitimate asset class [4] - The company aims to leverage Solana's high-speed transaction capabilities and staking rewards to create value for shareholders [2][4] Industry Context - Solana is recognized as a leading blockchain platform with a growing ecosystem of decentralized applications, which aligns with NewGen's strategic positioning [2] - The staking mechanism of Solana allows token holders to earn rewards while supporting network security and decentralization, presenting significant growth potential [2]

Core Insights - NewGenIvf Group Limited has launched First Fertility PGS Center Limited to target the Indian medical tourism market for fertility treatments [1][2] - The global fertility tourism market is projected to grow from US$709 million in 2023 to approximately US$13.08 billion by 2034, with a compound annual growth rate of 30.34% [2] - Thailand is becoming a preferred destination for fertility tourism due to its advanced medical infrastructure, cost-effective treatments, and supportive regulatory environment [2][4] Company Initiatives - First Fertility has developed culturally tailored services for Indian patients, including a dedicated hospitality lounge and Hindi-speaking staff [3] - The center offers comprehensive fertility treatments, including family balance through IVF, which is restricted in India but legally available in Thailand [3] - The initiative aims to create a culturally sensitive environment while providing access to advanced reproductive technologies [3] Market Positioning - Thailand's strategic advantages, such as visa-free entry for Indian nationals and a progressive regulatory environment, support the growth of the medical tourism sector [4] - First Fertility addresses the gap in culturally tailored fertility care for Indian patients, who represent a significant segment of the medical tourism market [4] - The CEO of NewGen emphasized the company's commitment to providing world-class fertility care while capitalizing on market opportunities in Southeast Asia [5]

Core Insights - NewGen has rebranded its MicroSort technology to NewGenSort, integrating it into its product offerings to enhance reproductive solutions in Asia [1][4] - NewGenSort technology allows for the separation of X and Y chromosome-bearing sperm cells, facilitating family planning and prevention of genetic diseases [2][3] Company Overview - NewGenIvf Group Limited is a comprehensive fertility services provider in Asia, offering a range of fertility treatments to couples and individuals [5] - The company operates clinics in Thailand, Cambodia, and Kyrgyzstan, providing services such as infertility treatments, egg and sperm donation, and surrogacy [5] Technology Applications - NewGen plans to utilize its sperm-sorting technology through two applications: MicroSort for gender selection and MacroSort for addressing male reproductive challenges [3] - MicroSort enables couples to balance family composition, while MacroSort focuses on avoiding sex-linked genetic disorders [3] Strategic Vision - The integration of NewGenSort is seen as a pivotal advancement for the company, expected to accelerate growth and expand market share across Asia [4] - The technology aims to provide personalized reproductive solutions, enhancing the overall family health and prosperity for clients [4]

Company Overview - NewGenIvf Group Limited is a comprehensive fertility services provider in Asia, assisting couples and individuals in accessing fertility treatments [5] - The company operates clinics in Thailand, Cambodia, and Kyrgyzstan, offering a full suite of services including infertility treatments, egg and sperm donation, and surrogacy [5] Reverse Stock Split Announcement - The company announced a reverse stock split at an exchange ratio of one (1) share for ten (10) shares, effective May 5, 2025 [1][2] - The number of outstanding Class A Ordinary Shares will decrease from 7,302,819 to approximately 730,282 shares as a result of the reverse stock split [3] - No fractional shares will be issued; shareholders entitled to a fractional share will receive one full post-split share [3] Impact on Securities - Following the reverse stock split, all options, warrants, and other convertible securities will be adjusted by dividing the number of shares by ten [4]

Core Viewpoint - NewGenIvf Group Limited has filed its annual report for the fiscal year ended December 31, 2024, indicating a strong liquidity position and strategic opportunities in the fertility services market in Asia [1][2]. Company Overview - NewGen is a comprehensive fertility services provider in Asia, dedicated to helping couples and individuals access fertility treatments [3]. - The company operates clinics in Thailand, Cambodia, and Kyrgyzstan, offering a full suite of services including infertility treatments, egg and sperm donation, and surrogacy [3]. - The management team has over a decade of experience in the fertility industry [3]. Financial Position - The company reported having $2.48 million in cash and a cash deposit of $1 million, significantly exceeding its current market capitalization of $1.48 million [2]. - NewGen has strengthened its balance sheet by settling all outstanding promissory notes and converting several mandatory additional notes into equity [2]. - The company has access to a $100 million equity line of credit facility, with approximately $7.1 million drawn to date, positioning it well for future strategic opportunities [2].

Share Structure - As of April 3, 2024, there are 10,149,386 Class A ordinary shares outstanding[42] - Major shareholders include Fong, Hei Yue Tina with 2,326,000 shares (22.9%) and Siu, Wing Fung Alfred with 1,779,500 shares (17.5%) [33] - A total of 8,319,988 warrants are outstanding, each exercisable at $11.50 per share[60] - The company is authorized to issue a maximum of 101,000,100 shares, including 100,000,000 Class A ordinary shares[42] - The Class A ordinary shares are listed on the Nasdaq Global Market under the symbol "NIVF"[39] Auditor and Financial Reporting - Following the Business Combination, Onestop has been engaged as the independent auditor of the company[66] - The previous auditor, Marcum Asia, was dismissed effective April 3, 2024, with no adverse opinions reported on their financial statements[67] - The annual report for the year ended December 31, 2023, has been filed with the SEC, including audited financial statements for both 2023 and 2022[75] - Marcum Asia has been engaged to provide a letter to the SEC regarding the disclosures made by PubCo in the report[70] - The company has not reported any disagreements or reportable events related to its financial statements during the specified periods[69] Legal and Compliance - The company has no material legal or administrative proceedings currently pending[38] - There are no significant changes reported in the company's financial condition[39] - The company is in compliance with the requirements for filing on Form 20-F, as certified by the Chief Executive Officer[78] Corporate Agreements and Plans - The merger agreement with NewGenIvf Limited has undergone multiple amendments, with the latest being on March 1, 2024[77] - The company has incorporated various agreements related to its operations, including lease contracts and service agreements, into its registration statement[77] - The financial disclosures include a Receivables Purchase Agreement dated December 28, 2022, which is part of the company's financial strategy[78] - The report includes a list of subsidiaries, which is essential for understanding the company's structure and operations[77] - The company has established a 2024 Share Incentive Plan to align employee interests with shareholder value[77]

Core Viewpoint - NewGenIvf Group Limited has secured $5.2 million in strategic funding to support its expansion into the UAE, with plans to establish a fertility clinic in Dubai, leveraging advanced technology and aiming to serve a diverse patient base [1][5][6] Funding Arrangements - The company has entered into two funding arrangements with an investor, with the potential to raise a total of up to $30.8 million [1] - The fourth tranche of debt financing was completed, involving a senior convertible note of $2 million with an interest rate of 14.75% per annum [2] - A new Securities Purchase Agreement was established, allowing for the sale of additional convertible notes not exceeding $25.6 million [3] Expansion Plans - The funding will be utilized to establish a state-of-the-art fertility clinic in Dubai, which will offer a comprehensive suite of services including IVF with gender selection, egg donation, and surrogacy [5] - The clinic aims to attract patients from the UAE, EU countries, and neighboring regions, particularly India, where there is significant demand for fertility services [5] - Construction of the facility is expected to begin in the second quarter of 2025, with an opening targeted for the fourth quarter of the same year [5] Company Background - NewGen is a comprehensive fertility services provider in Asia, with clinics located in Thailand, Cambodia, and Kyrgyzstan, offering a full suite of infertility treatments [7] - The company is dedicated to increasing access to fertility treatments and has a management team with over a decade of experience in the fertility industry [7]